TrialCancer immunology, immunotherapy : CII2012

Autologous cytokine-induced killer cell immunotherapy in lung cancer: a phase II clinical study.

Runmei Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.